Ibrahim Demirci
Overview
Explore the profile of Ibrahim Demirci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Demirci I, Demir T, Dagdelen S, Haymana C, Tasci I, Atmaca A, et al.
Intern Med J
. 2021 Dec;
52(3):379-385.
PMID: 34939733
Background: It is well documented that patients with chronic metabolic diseases, such as diabetes and obesity, are adversely affected by the COVID-19 pandemic. However, when the subject is rare metabolic...
12.
Emral R, Haymana C, Demirci I, Tasci I, Sahin M, Cakal E, et al.
Diabetes Ther
. 2021 Sep;
12(11):2871-2872.
PMID: 34559403
No abstract available.
13.
Emral R, Haymana C, Demirci I, Tasci I, Sahin M, Cakal E, et al.
Diabetes Ther
. 2021 Aug;
12(11):2857-2870.
PMID: 34398433
Introduction: To investigate the effect of preexisting treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) on COVID-19-related hospitalization and mortality in patients with type 2 diabetes mellitus (T2DM). Methods: A multicenter, retrospective...
14.
Sahin I, Haymana C, Demir T, Demirci I, Tasci I, Atmaca A, et al.
Exp Clin Endocrinol Diabetes
. 2021 Aug;
130(2):115-124.
PMID: 34384122
Purpose: While obesity is related to more severe outcomes of coronavirus disease 2019 (COVID-19), factors leading to poor prognosis still remain unclear. The present study evaluated the outcomes of COVID-19...
15.
Haymana C, Demirci I, Tasci I, Cakal E, Salman S, Ertugrul D, et al.
Endocrine
. 2021 Jun;
73(2):261-269.
PMID: 34156609
Purpose: New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. However, there are insufficient data about the effect of hyperglycemia on COVID-19 prognosis in non-diabetic patients....
16.
Sahin M, Haymana C, Demirci I, Tasci I, Rifat E, Unluturk U, et al.
Clin Endocrinol (Oxf)
. 2021 Apr;
95(4):628-637.
PMID: 33872399
Background: There are scarce published data in differentiated thyroid cancer patients about new coronavirus disease 2019 (COVID-19) disease outcomes and mortality. Here, we evaluated COVID-19 infection outcomes and mortality in...
17.
Demirci I, Haymana C, Candemir B, Meric C, Yuksel B, Eser M, et al.
Endokrynol Pol
. 2021 Mar;
72(3):232-237.
PMID: 33749808
Introduction: The risk of cardiometabolic diseases is increased in patients with hypogonadism. The triglyceride-glucose (TyG) index is a novel surrogate marker of insulin resistance and is associated with cardiovascular diseases....
18.
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul
Satman I, Demirci I, Haymana C, Tasci I, Salman S, Ata N, et al.
Diabetes Res Clin Pract
. 2021 Mar;
174:108753.
PMID: 33741352
Aims: Type 2 diabetes mellitus (T2DM) is a risk factor for severe COVID-19. Our aim was to compare the clinical outcomes of patients with and without T2DM during the first...
19.
Sonmez A, Demirci I, Haymana C, Tasci I, Dagdelen S, Salman S, et al.
J Diabetes
. 2021 Mar;
13(7):585-595.
PMID: 33655669
Background: Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe course in patients with type 2 diabetes mellitus (T2DM). However, severe adverse outcomes are not...
20.
Sabuncu T, Sonmez A, Eren M, Sahin I, Corapcioglu D, Ucler R, et al.
Prim Care Diabetes
. 2020 Dec;
15(2):332-339.
PMID: 33277201
Background: The present survey aimed to find out the demographical and clinical characteristics of patients with hypertension in a population with type 2 diabetes mellitus (T2DM) in Turkey. Methods: Patients...